BRIEF-Gilead receives approval in Canada for Odefsey for treatment of HIV-1 infection

* Gilead receives approval in Canada for Odefsey for the treatment of HIV-1 infection Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.